CA50971-2B - 0x0000000000006F74
Males & Females of Non-Childbearing Potential
Badger
* Stipend may pay up to reflected amount.
Start Date:
September 22, 2026 - 1:45pm
End Date:
October 22, 2026 - 11:15am
Study Details
Study Number: CA50971
Group Number: 2B
Study Requirement: Healthy Normal Male and Female
Stipend: up to $5,750.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32.44
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed to treat Alzheimer's Disease.
Route of Administration: Oral
Blood Draws: 21
Study Schedule
Schedule Type: Long Term
Study Length: 10 Night Stay & 2 Phone Calls
Screening Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 9/15/2026 |
| Friday | 9/18/2026 |
| Monday | 9/21/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 9/15/2026 |
| Friday | 9/18/2026 |
| Monday | 9/21/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Tuesday | 9/22/2026 1:45:00 PM | Friday | 10/2/2026 8:15:00 AM | 1 | Lincoln |
| Phone participant | Thursday | 10/8/2026 11:15:00 AM | 1 | Lincoln | ||
| Phone participant | Thursday | 10/22/2026 11:15:00 AM | 1 | Lincoln |
